Home / Going-concern warnings / Dermata Therapeutics, Inc.
Filed 2026-03-26 路 Form 10-K 路 Accession 0001493152-26-012992 nano
Price before filing: $1.46 (2026-03-25 close, split/dividend-adjusted)
Market cap at flag: $5.3M (2026-03-26) 路 Latest: $3.5M (2026-10-16)
| Window | DRMA | SPY | vs SPY | |
|---|---|---|---|---|
| 30 days | -17.1% | +8.9% | -26.0% | 2026-04-27 |
| 90 days | -17.1% | +11.9% | -29.0% | 2026-06-24 |
| 180 days | -21.2% | +18.3% | -39.6% | 2026-09-22 |
Return from the last close before the filing date to the first close on/after the window end. Pending windows have not fully elapsed. Past performance says nothing certain about the future.
90 days before the flag: 1 insider bought $1K (1 purchase)
30 days after: none reported.
| Date | Insider | Type | Shares | Price | Value | 10b5-1 plan | Source |
|---|---|---|---|---|---|---|---|
| 2026-02-17 | Bedoya-Toro Munera Maria E SVP, Regulatory Affairs | Purchase | 1,000 | $1.27 | $1K | no | Form 4 |
| 2026-03-26: red flag filed | |||||||
Open-market purchases and sales (Form 4 codes P and S) by officers, directors and 10% owners, by transaction date, from 2025-12-26 to 2026-04-25. Excludes option exercises, grants, gifts and tax withholding. Amended filings replace the originals; joint filings count once. Foreign private issuers do not file Form 4. Many insider sales are pre-scheduled (10b5-1 plans) and are not by themselves a sign of wrongdoing.
"These factors raise substantial doubt about our ability to continue as a going concern for the one-year period following the date that these financial statements were issued."
Quoted from the filing. Source
The filing states that substantial doubt exists about the company's ability to continue as a going concern: it may not have enough cash to last the next 12 months. Expect dilution, debt deals or worse. An auditor's going-concern paragraph is the strongest form of this warning.
Source: management disclosure in Form 10-K (period 2025-12-31)
Why this score: also within 90 days: Auditor change
Read the original filing on SEC.gov →
Not investment advice. Automated summary; verify against the filing.
The week's most serious auditor changes, restatements, late filings and going-concern warnings, in plain English. Free. Unsubscribe anytime.
Subscribe to the newsletter →
The signup form didn't load here (often an ad or privacy blocker). This opens beehiiv's secure signup page.
Form not showing? Subscribe on beehiiv →
Newsletter delivered by beehiiv. See our privacy policy.